Avricore Health Inc. (AVCRF)
OTCMKTS · Delayed Price · Currency is USD
0.0586
-0.0076 (-11.41%)
Aug 8, 2025, 3:58 PM EDT
Avricore Health Market Cap
Avricore Health has a market cap or net worth of $5.52 million as of August 8, 2025. Its market cap has decreased by -54.25% in one year.
Market Cap
5.52M
Enterprise Value
4.59M
Revenue
2.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.06
Market Cap Chart
Since February 27, 2004, Avricore Health's market cap has increased from 1.81M to 5.52M, an increase of 204.73%. That is a compound annual growth rate of 5.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2025 | 5.90M | 52.30% |
| Dec 31, 2024 | 3.87M | -69.82% |
| Dec 27, 2023 | 12.83M | -44.45% |
| Dec 30, 2022 | 23.10M | 87.31% |
| Dec 31, 2021 | 12.33M | 136.64% |
| Dec 31, 2020 | 5.21M | 332.19% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 532.81M |
| Glass House Brands | 467.07M |
| Northwest Biotherapeutics | 366.31M |
| CytoDyn | 347.26M |
| American Oncology Network | 330.70M |